Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.01 - $7.45 $441,985 - $1.09 Million
146,839 New
146,839 $772,000
Q2 2023

Aug 14, 2023

SELL
$4.3 - $9.48 $144,041 - $317,561
-33,498 Reduced 8.87%
344,367 $2.38 Million
Q1 2023

May 12, 2023

SELL
$4.81 - $8.88 $15,574 - $28,753
-3,238 Reduced 0.85%
377,865 $2.34 Million
Q4 2022

Feb 13, 2023

SELL
$6.52 - $8.05 $908,340 - $1.12 Million
-139,316 Reduced 26.77%
381,103 $2.73 Million
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $186,721 - $308,325
24,666 Added 4.98%
520,419 $4.03 Million
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $4.84 Million - $9.11 Million
-960,488 Reduced 65.96%
495,753 $3.79 Million
Q1 2022

May 16, 2022

SELL
$7.09 - $89.45 $28.3 Million - $357 Million
-3,988,559 Reduced 73.25%
1,456,241 $11.2 Million
Q4 2021

Feb 11, 2022

SELL
$80.85 - $128.49 $60.2 Million - $95.7 Million
-745,114 Reduced 12.04%
5,444,800 $462 Million
Q3 2021

Nov 15, 2021

BUY
$81.97 - $106.94 $11.8 Million - $15.5 Million
144,539 Added 2.39%
6,189,914 $594 Million
Q2 2021

Aug 16, 2021

BUY
$77.2 - $126.54 $102 Million - $167 Million
1,320,231 Added 27.94%
6,045,375 $562 Million
Q1 2021

May 17, 2021

BUY
$110.45 - $164.47 $26.9 Million - $40 Million
243,115 Added 5.42%
4,725,144 $536 Million
Q4 2020

Feb 12, 2021

BUY
$60.78 - $154.03 $85.2 Million - $216 Million
1,402,406 Added 45.54%
4,482,029 $658 Million
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $8.93 Million - $11.7 Million
-198,237 Reduced 6.05%
3,079,623 $182 Million
Q2 2020

Aug 14, 2020

BUY
$42.74 - $66.25 $5.28 Million - $8.19 Million
123,615 Added 3.92%
3,277,860 $177 Million
Q1 2020

May 14, 2020

SELL
$38.18 - $73.95 $6.5 Million - $12.6 Million
-170,330 Reduced 5.12%
3,154,245 $150 Million
Q4 2019

Feb 11, 2020

BUY
$13.9 - $76.65 $46.2 Million - $255 Million
3,324,575 New
3,324,575 $239 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.